A detailed history of Bvf Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 3,075,907 shares of MIRM stock, worth $130 Million. This represents 3.81% of its overall portfolio holdings.

Number of Shares
3,075,907
Previous 4,370,024 29.61%
Holding current value
$130 Million
Previous $149 Million 19.71%
% of portfolio
3.81%
Previous 4.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$33.68 - $44.74 $43.6 Million - $57.9 Million
-1,294,117 Reduced 29.61%
3,075,907 $120 Million
Q3 2023

Nov 14, 2023

BUY
$24.63 - $32.85 $108 Million - $144 Million
4,370,024 New
4,370,024 $138 Million
Q1 2022

May 16, 2022

SELL
$15.5 - $23.93 $6.76 Million - $10.4 Million
-435,936 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$13.95 - $20.18 $6.08 Million - $8.8 Million
435,936 New
435,936 $8.68 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.55B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.